Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Enzo Biochem IncENZ-2.261.711.091.74-11.83%-4.48%0.00(not set)$0.11106,700$0.99

Detail of Enzo Biochem Inc

 
CEO
Ms. Kara Cannon
Employees
125
Industry
Diagnostics & Research
Sector
Healthcare
Market cap
$52M

Company details

Enzo Biochem Inc. is a life sciences company that plays a significant role in the development, manufacturing, and marketing of innovative health care products. It primarily operates in the biotechnology sector, providing specialized diagnostic services and technologies that have a profound impact on clinical laboratory diagnostics. The company is known for its comprehensive portfolio of products in areas such as molecular diagnostics, immunology, and tissue processing solutions. These products cater to research and clinical labs looking to enhance their diagnostic capabilities. Enzo Biochem’s offerings support personalized medicine initiatives, potentially leading to more effective medical treatments and improved patient outcomes. Founded in 1976, the company is headquartered in New York and has established itself as a key player at the intersection of life sciences and diagnostics, contributing to advancements in medical technology and laboratory efficiency.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
NI
Revenue (Rev)
$30.31M
Cost of goods (CoG)
-$16.86M
Gross profit (GP)
$13.46M
Operating expense (OE)
-$24.59M
Research and development (R&D)
-$2.35M
General and administrative (G&A)
-$22.23M
Operating income (OI)
-$11.13M
Other income expense (OIE)
-$933,000.00
Pretax income (PI)
-$7.21M
Net income (NI)
-$22.84M
Enzo Biochem Inc
ENZ • XNYS • US
$0.99
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.10
Payout ratio
0.00%
EPS
-$0.44
Margin profit
-75.34%
52 week low
$0.00
52 week high
$0.00
50-day simple moving average
$0.00
200-day simple moving average
$0.00
Percent held by insiders
22.60%
Percent held by institutions
32.29%
Dividend yield
19.61%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
ENZ 0.00%
eps change
ENZ 0.00%